Sign inJoin waitlistJoin the waitlist

Jessica K. Altman

Professor · Feinberg School of Medicine

Credentials: · · ·

History

Feinberg School of Medicine
Present

McGaw Medical Center of Northwestern University
Until 2007
University of Chicago
Until 2004
University of Pittsburgh School of Medicine
2001

Research

Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Blood · 2017 · 1,232 citations
Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study
The Lancet Oncology · 2017 · 424 citations

Leonidas Platanias
59 papers
MT
Martin Tallman
49 papers
Amir Fathi
21 papers
OF
Olga Frankfurt
19 papers
Richard Stone
19 papers
Alexander Perl
18 papers
Eunice Wang
16 papers
Madina Sukhanova
16 papers
ES
Eytan Stein
15 papers · 3 as a resident
James Foran
15 papers
Hagop Kantarjian
14 papers
Yasmin Abaza
14 papers

Clinical trials

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia
Principal investigator · Active not recruiting · Phase 1
Northwestern University
2018–2027
Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML
Principal investigator · Terminated · Phase 1
Northwestern University
2015–2016
A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving
Principal investigator · Completed · Phase 1
Epizyme, Inc.
2012–2016
The Role of Maintenance Oral Clofarabine in Older Adults With Acute Myeloid Leukemia
Principal investigator · Withdrawn · Phase 1
Northwestern University
2011